A double-blind, randomized, placebo-controlled trial of acupuncture for the treatment of childhood persistent allergic rhinitis

被引:97
|
作者
Ng, DK
Chow, PY
Ming, SP
Hong, SH
Lau, S
Tse, D
Kwong, WK
Wong, MF
Wong, WH
Fu, YM
Kwok, KL
Li, HD
Ho, JC
机构
[1] Kwong Wah Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China
[2] Kwong Wah Hosp, Chinese Med Clin Res & Serv Ctr, Hong Kong, Hong Kong, Peoples R China
[3] Kwong Wah Hosp, Dept Physiotherapy, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescents, Hong Kong, Hong Kong, Peoples R China
关键词
acupuncture; allergic rhinitis; rhinitis; children; pediatric; trial; randomized; controlled trial; complementary therapy;
D O I
10.1542/peds.2004-0744
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. To compare active acupuncture with sham acupuncture for the treatment of persistent allergic rhinitis among children. Methods. Subjects with persistent allergic rhinitis were recruited from the pediatric outpatient clinic. They were randomized to receive either active acupuncture or sham acupuncture. Main outcome measures included daily rhinitis scores, symptom-free days, visual analog scale scores for immediate effects of acupuncture, daily relief medication scores, blood eosinophil counts, serum IgE levels, nasal eosinophil counts, patients' and parents' preferences for treatment modalities, and adverse effects. Results. Eighty-five patients were recruited from the pediatric outpatient clinic at Kwong Wah Hospital, in Hong Kong. Thirteen patients withdrew before randomization; 35 patients (mean age: 11.7 +/- 3.2 years) were randomized to receive active acupuncture for 8 weeks, and 37 patients (mean age: 11 +/- 3.8 years) were randomized to receive sham acupuncture for 8 weeks. Acupuncture was performed twice per week for both groups. Both the assessing pediatricians and the patients were blinded. There were significantly lower daily rhinitis scores and more symptom-free days for the group receiving active acupuncture, during both the treatment and follow-up periods. The visual analog scale scores for immediate improvement after acupuncture were also significantly better for the active acupuncture group. There was no significant difference in the following outcome measures between the active and sham acupuncture groups: daily relief medication scores, blood eosinophil counts, serum IgE levels, and nasal eosinophil counts, except for the IgE levels before and 2 months after acupuncture in the sham acupuncture group. No severe adverse effects were encountered. Numbness, headache, and dizziness were found in both the active and sham acupuncture groups, with no difference in incidence, and the effects were self-limiting. Conclusions. This study showed that active acupuncture was more effective than sham acupuncture in decreasing the symptom scores for persistent allergic rhinitis and increasing the symptom-free days. No serious adverse effect was identified. A large-scale study is required to confirm the safety of acupuncture for children.
引用
收藏
页码:1242 / 1247
页数:6
相关论文
共 50 条
  • [1] A Double-Blind, Randomized, Placebo-Controlled Trial of Acupuncture for the Treatment of Childhood Persistent Allergic Rhinitis
    Raymund Pothmann
    Daniel K. Ng
    Pok-yu Chow
    Shun-pei Ming
    Siu-hung Hong
    Sunny Lau
    Debbie Tse
    Handong Li
    Jackson C. Ho
    Wilson K. Kwong
    Mui-fong Wong
    Wilfred H. Wong
    Yu-ming Fu
    Ka-li Kwok
    [J]. Deutsche Zeitschrift für Akupunktur, 2008, 51 (1) : 54 - 55
  • [2] Rhinophototherapy in persistent allergic rhinitis: randomised double-blind placebo-controlled study
    Bella, Z.
    Kiricsi, A.
    Racz, Viharosne Dosa E.
    Kadocsa, E.
    [J]. ALLERGY, 2009, 64 : 452 - 452
  • [3] Nasal cellulose powder in children with allergic rhinitis, a randomized, double-blind, placebo-controlled trial
    Klangkalya, N.
    Manuyakorn, W.
    Kamchaisatian, W.
    Benjaponpitak, S.
    [J]. ALLERGY, 2017, 72 : 428 - 428
  • [4] Efficacy of Nasal Cellulose Powder in the Symptomatic Treatment of Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Trial
    Manuyakorn, Wiparat
    Klangkalya, Natchanun
    Kamchaisatian, Wasu
    Benjaponpitak, Suwat
    Sasisakulporn, Cherapat
    Jotikasthira, Wanlapa
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2017, 9 (05) : 446 - 452
  • [5] Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study
    Potter, Paul
    Maspero, Jorge F.
    Vermeulen, Jan
    Barkai, Laszlo
    Nemeth, Ildiko
    Baillieau, Rene A.
    Garde, Jesus M.
    Giralt, Josep
    Domenech, Alejandro
    Izquierdo, Inaki
    Nieto, Antonio
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2013, 24 (02) : 144 - 150
  • [6] Montelukast in the treatment of spring allergic rhinitis in a large, double-blind, randomized, placebo-controlled study
    Malmstrom, K
    Hampel, FC
    Philip, G
    Malice, MP
    Reiss, TF
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S157 - S157
  • [7] Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study
    Rimmer, J.
    Peake, H. L.
    Santos, C. M. C.
    Lean, M.
    Bardin, P.
    Robson, R.
    Haumann, B.
    Loehrer, F.
    Handel, M. L.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (01): : 8 - 14
  • [8] Double-Blind Placebo-Controlled Trial of Bepotastine Salicylate in Patients With Allergic Rhinitis
    Mo, Ji-Hun
    Jeong, Jin Hyeok
    Kim, Tae Hoon
    Kim, Seon-Tae
    Kim, Soo Whan
    Lee, Kun Hee
    Hong, Seung-No
    Kim, Hyo Yeol
    Kim, Dae Woo
    Kim, Dong-Young
    Kim, Chang-Hoon
    Cho, Seok Hyun
    Rhee, Chae-Seo
    [J]. LARYNGOSCOPE, 2021, 131 (03): : E702 - E709
  • [9] Clinical Efficacy of Potassium Humate in the Treatment of Allergic Rhinitis: Double-Blind Placebo-Controlled Trial
    Gandy, Justin J.
    Meeding, Johanna P.
    Snyman, Jacques R.
    van Rensburg, Constance E. Jansen
    [J]. DRUG DEVELOPMENT RESEARCH, 2010, 71 (06) : 358 - 363
  • [10] Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring
    Philip, G
    Malmstrom, K
    Hampel, FC
    Weinstein, SF
    LaForce, CF
    Ratner, PH
    Malice, MP
    Reiss, TF
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (07): : 1020 - 1028